Total Payments
$3,377
2024 Payments
$383.54
Companies
28
Transactions
204
Medicare Patients
15,588
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$3,377 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,377 | 204 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $577.82 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $363.79 | 18 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $250.43 | 15 | $0 (2024) |
| PFIZER INC. | $249.29 | 16 | $0 (2023) |
| Celgene Corporation | $223.12 | 15 | $0 (2019) |
| Amgen Inc. | $218.08 | 10 | $0 (2024) |
| GENZYME CORPORATION | $208.88 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $173.89 | 11 | $0 (2023) |
| Lilly USA, LLC | $153.37 | 10 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $136.26 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $383.54 | 17 | SUN PHARMACEUTICAL INDUSTRIES INC. ($66.49) |
| 2023 | $365.21 | 19 | Dermavant Sciences, Inc. ($52.50) |
| 2022 | $133.07 | 7 | Sun Pharmaceutical Industries Inc. ($61.71) |
| 2021 | $466.91 | 28 | AbbVie Inc. ($137.64) |
| 2020 | $285.34 | 17 | AbbVie Inc. ($105.88) |
| 2019 | $438.35 | 27 | Genentech USA, Inc. ($92.52) |
| 2018 | $470.51 | 35 | AbbVie, Inc. ($116.94) |
| 2017 | $833.64 | 54 | Novartis Pharmaceuticals Corporation ($197.70) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Dermatology | ||||||
| 07/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DERMATOLOGY | ||||||
| 05/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Dermatology | ||||||
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.31 | General |
| Category: Immunology | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Immunology | ||||||
| 02/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Dermatology | ||||||
| 01/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: DERMATOLOGY | ||||||
| 01/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Dermatology | ||||||
| 12/04/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 11/14/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: Immunology | ||||||
| 09/12/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Dermatology | ||||||
| 09/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: DERMATOLOGY | ||||||
| 08/14/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Immunology | ||||||
| 08/01/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,455 | 6,548 | $901,568 | $321,822 |
| 2022 | 33 | 3,832 | 6,855 | $950,681 | $336,989 |
| 2021 | 33 | 4,106 | 7,245 | $984,884 | $367,528 |
| 2020 | 32 | 4,195 | 6,958 | $951,134 | $336,478 |
Total Patients
15,588
Total Services
27,606
Medicare Billing
$1.4M
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,017 | 1,793 | $209,781 | $100,558 | 47.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 542 | 748 | $139,876 | $46,864 | 33.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 433 | 712 | $103,240 | $23,493 | 22.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 56 | 74 | $33,300 | $22,203 | 66.7% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 15 | 242 | $36,300 | $20,901 | 57.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 205 | 255 | $50,235 | $17,812 | 35.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 74 | 109 | $45,889 | $11,572 | 25.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 46 | 51 | $28,152 | $11,203 | 39.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 305 | 1,675 | $70,350 | $7,976 | 11.3% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 56 | 71 | $17,750 | $6,452 | 36.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 58 | 70 | $24,640 | $6,378 | 25.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 119 | 158 | $15,326 | $5,619 | 36.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 122 | 140 | $9,800 | $5,061 | 51.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 35 | 39 | $17,277 | $3,638 | 21.1% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 21 | 28 | $9,240 | $3,504 | 37.9% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 57 | 62 | $7,626 | $3,275 | 42.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 17 | 26 | $14,872 | $3,230 | 21.7% |
| 69100 | Biopsy of ear | Office | 2023 | 60 | 64 | $10,240 | $3,177 | 31.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 39 | 42 | $7,098 | $2,832 | 39.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 20 | $12,180 | $2,736 | 22.5% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 20 | 25 | $13,975 | $2,668 | 19.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $4,900 | $2,046 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 24 | $3,654 | $2,031 | 55.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 17 | $3,570 | $1,529 | 42.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $2,412 | $1,255 | 52.0% |
About Dr. Daniel Smith, MD
Dr. Daniel Smith, MD is a Specialist healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023081130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Smith, MD has received a total of $3,377 in payments from pharmaceutical and medical device companies, with $383.54 received in 2024. These payments were reported across 204 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,377).
As a Medicare-enrolled provider, Smith has provided services to 15,588 Medicare beneficiaries, totaling 27,606 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Asheville, NC
- Active Since 02/09/2006
- Last Updated 09/03/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1023081130
Products in Payments
- COSENTYX (Biological) $253.72
- EUCRISA (Drug) $249.29
- Humira (Biological) $212.79
- ILUMYA (Biological) $159.54
- DUPIXENT (Drug) $154.90
- TALTZ (Drug) $153.37
- HUMIRA (Biological) $148.04
- SKYRIZI (Biological) $145.72
- Otezla (Drug) $131.10
- DUPIXENT (Biological) $125.05
- REMICADE (Biological) $109.47
- Erivedge (Biological) $106.71
- VTAMA (Drug) $87.02
- Enbrel (Biological) $86.98
- Sotyktu (Drug) $84.46
- COSENTYX (Drug) $71.41
- BLU-U (Medical Supply) $66.51
- DUPIXENT DUPILUMAB INJECTION (Biological) $65.19
- BLU-U (Device) $60.26
- Cimzia (Drug) $59.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Asheville
Charles Buzzanell, M.d, M.D
Specialist — Payments: $7,870
Specialist $7,870
Peter Jaber, Md, MD
Specialist — Payments: $4,838
Specialist $4,838
Mrs. Brenda Draper, M.d, M.D
Specialist — Payments: $4,640
Specialist $4,640
Virginia Waymouth, Agacnp-Bc, AGACNP-BC
Specialist — Payments: $1,996
Specialist $1,996
Dr. Marilee Mcginness, M.d, M.D
Specialist — Payments: $1,462
Specialist $1,462
Dr. Calvin Bard, M.d, M.D
Specialist — Payments: $1,018
Specialist $1,018